Takip et
Nick Cox
Nick Cox
Senior Director of Chemical Biology, Novo Nordisk
novonordisk.com üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Integrin‐Targeting Knottin Peptide–Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation
N Cox, JR Kintzing, M Smith, GA Grant, JR Cochran
Angewandte Chemie International Edition 55 (34), 9894-9897, 2016
832016
Copper‐Catalyzed Reduction of Alkyl Triflates and Iodides: An Efficient Method for the Deoxygenation of Primary and Secondary Alcohols
H Dang, N Cox, G Lalic
Angewandte Chemie International Edition 53 (3), 752-756, 2014
642014
NHC–copper hydrides as chemoselective reducing agents: catalytic reduction of alkynes, alkyl triflates, and alkyl halides
N Cox, H Dang, AM Whittaker, G Lalic
Tetrahedron 70 (27-28), 4219-4231, 2014
472014
Catalytic Asymmetric Synthesis of Cyclic Ethers Containing an α‐Tetrasubstituted Stereocenter
N Cox, MR Uehling, KT Haelsig, G Lalic
Angewandte Chemie International Edition 18 (52), 4878-4882, 2013
452013
Niclosamide suppresses acute myeloid leukemia cell proliferation through inhibition of CREB-dependent signaling pathways
HD Chae, N Cox, GV Dahl, NJ Lacayo, KL Davis, S Capolicchio, M Smith, ...
Oncotarget 9 (4), 4301, 2018
262018
Tethered NHC ligands for stereoselective alkyne semihydrogenations
F Pape, JF Teichert
Synthesis 49 (11), 2470-2482, 2017
252017
An inter-laboratory retrospective analysis of immunotoxicological endpoints in non-human primates: Flow cytometry immunophenotyping
CM Krejsa, MB Neradilek, NL Polissar, N Cox, D Clark, L Cowan, ...
Journal of Immunotoxicology 10 (4), 361-372, 2013
122013
Evaluation of VGF peptides as potential anti-obesity candidates in pre-clinical animal models
LS Dalbøge, JM Jacobsen, S Mehrotra, AJ Mercer, N Cox, F Liu, ...
Peptides 136, 170444, 2021
102021
SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway
HD Chae, N Cox, S Capolicchio, JW Lee, N Horikoshi, S Kam, AA Ng, ...
Bioorganic & Medicinal Chemistry Letters 29 (16), 2307-2315, 2019
92019
Small molecule screen for inhibitors of expression from canonical CREB response element-containing promoters
B Mitton, K Hsu, R Dutta, BC Tiu, N Cox, KG McLure, HD Chae, M Smith, ...
Oncotarget 7 (8), 8653, 2016
72016
Copper-catalyzed semi-reduction of alkynes
N Cox, H Dang, AM Whittaker, G Lalic
Org. Synth 93, 385-398, 2016
72016
Minutes: Board of Directors
J Mann, SI Director, A Odell, E Director, M Smith, N Cox, MMSE Director, ...
32020
An investigational in vivo base editing medicine targeting ANGPTL3, VERVE-201, achieves potent and LDLR-independent liver editing in mouse models
R Lee, J Denizio, T Mizoguchi, C Dutta, V Clendaniel, R Garrity, N Cox, ...
European Heart Journal 44 (Supplement_2), ehad655. 2521, 2023
12023
The Salicylamide Derivative, Niclosamide, Inhibits CREB Function in Acute Myeloid Leukemia Cells In Vitro and In Vivo
HD Chae, N Cox, X Zhang, JW Lee, D Morgens, MC Bassik, M Smith, ...
Blood 128 (22), 1647, 2016
2016
Innentitelbild: Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation (Angew. Chem. 34/2016).
N Cox, JR Kintzing, M Smith, GA Grant, JR Cochran
Angewandte Chemie 128 (34), 2016
2016
Inside Cover: Integrin‐Targeting Knottin Peptide–Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation (Angew. Chem. Int. Ed. 34/2016)
N Cox, JR Kintzing, M Smith, GA Grant, JR Cochran
Angewandte Chemie International Edition 55 (34), 9796-9796, 2016
2016
Engineered knottin peptide-drug conjugates selectively deliver small molecules to brain tumors in mice
N Cox, J Kintzing, N Currier, S Ackerman, S DePorter, M Smith, G Grant, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016
2016
Development of Practical Synthetic Tools Using Copper and Gold Catalysis
N Cox
2014
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–18